Global DTP Vaccines Market Report 2024

DTP Vaccines Global Market Report 2023 – By Product Type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
DTP Vaccines Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

DTP vaccines refer to a combination vaccine given intramuscularly to protect children under the age of 7 from diphtheria, tetanus, and whooping cough. It aids kids in acquiring resistance to the three bacterial illnesses, diphtheria, tetanus, and pertussis, which are all fatal.

The main types of products in DTP vaccines are DTaP, TD, and Tdap. Diphtheria, tetanus, and whooping cough (DTaP) vaccines help children under the age of seven build protection against three lethal bacteria-borne diseases: diphtheria, tetanus, and whooping cough (pertussis). The different types of diseases include diphtheria, pertussis, and tetanus and involve various sectors such as hospitals, clinics, and vaccination centers.

The global DTP vaccine market is segmented -

1) By Product Type: DTaP, TD, Tdap

2) By Disease: Diphtheria, Pertussis, Tetanus.

3) By End User: Hospitals, Clinics, Vaccination Centers

The global DTP vaccines market size will grow from $6.02 billion in 2022 to $6.39 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the DTP vaccines is expected to grow from $7.79 billion in 2027 at a CAGR of 5.1%.

Major players in the DTP vaccines market are Merck & Co., Sanofi, GSK, Lanzhou Institute of Biological Products, Novartis AG, Pfizer Inc., Johnson & Johnson, Seqirus, AJ Vaccines, and Bionet-Asia.

Governments all over the world are encouraging the development of DTP vaccines in order to prevent the spread of the diseases. Countries such as India have the Universal Immunization Programme that aims to provide recommended vaccines against tuberculosis, polio, and other diseases including diphtheria, tetanus, and whooping cough for all Indian children. The country regularly conducts vaccination drives, which is expected to positively impact the growth of the market. These initiatives are expected to drive the  DTP vaccines market growth in the forecast period.

Inadequate vaccine access in developing countries is expected to limit the growth of the global DTP vaccine market. According to the World Health Organization’s global estimates, around 19.4 million infants did not have access to DTP vaccines, and around 60% of these children live in underdeveloped and developing countries. Countries such as the Central African Republic, Chad, Equatorial Guinea, Guinea, Samoa, Somalia, South Sudan, the Syrian Arab Republic, and Ukraine have less than 50% coverage of DTP vaccination. Lack of access to vaccines in underdeveloped countries is expected to hamper DTP vaccines market growth.

Companies in the DTP vaccines market are increasingly investing in manufacturing DTP combination vaccines, which reduce the need for multiple vaccination shots for immunisation against infectious diseases. DTP combination vaccines such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib), and hexavalent (DTP-Hib-HepB-IPV) are available to provide the same protection as individual vaccine shots given separately.

In May 2020, Merck acquired Thermis, a company focused on vaccines and immuno-modulation therapies for infectious diseases, for an undisclosed amount. Thermis is involved in the discovery, development, and production of vaccines with a sophisticated and versatile technology platform. Merck is expected to leverage the vaccine technology enhanced by Thermis, and the company will become a fully-owned subsidiary of Merck after the completion of this deal.

North America was the largest region in the DTP vaccines market in 2022.

The regions covered in the global DTP vaccine market analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the DTP vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The DTP vaccine market consists of sales of Daptacel, Infanrix, Kinrix, Paediarix, Pentacel, Quadracel, and Vaxelis vaccines. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The DTP vaccines market research report is one of a series of new reports from The Business Research Company that provides DTP vaccines market statistics, including global market size, regional shares, competitors with a DTP vaccines market share, detailed DTP vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the DTP vaccines industry. This DTP vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction and Market Characteristics

    6.1. General Market Definition

    6.2. Summary

    6.3. DTP Vaccines Market Definition and Segmentations

    6.4. Market Segmentation By Product Type

    6.4.1. DTaP

    6.4.2. TD

    6.4.3. Tdap

    6.5. Market Segmentation By Disease

    6.5.1. Diphtheria

    6.5.2. Pertussis

    6.5.3. Tetanus

    6.6. Market Segmentation By End User

    6.6.1. Hospitals

    6.6.2. Clinics

    6.6.3. Vaccination Centers

    7. Major Market Trends

    7.1. Development Of Combination Vaccines

    7.2. Strategic Acquisitions

    7.3. Robust Research And Development

    7.4. Artificial Intelligence In Vaccine Development

    8. Global Market Size And Growth

    8.1. Market Size

    8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

    8.2.1. Market Drivers 2016 – 2021

    8.2.2. Market Restraints 2016 – 2021

    8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    8.3.1. Market Drivers 2021 – 2026

    8.3.2. Market Restraints 2021 – 2026

    9. Global Market Segmentation

    9.1. Global DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    9.2. Global DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    9.3. Global DTP Vaccines Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    10. Global Market, Regional And Country Analysis

    10.1. Global DTP Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    10.2. Global DTP Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11. Asia-Pacific Market

    11.1. Summary

    11.2. Market Overview

    11.2.1. Region Information

    11.2.2. Market Information

    11.2.3. Background Information

    11.2.4. Government Initiatives

    11.2.5. Regulations

    11.2.6. Regulatory Bodies

    11.2.7. Major Associations

    11.2.8. Taxes Levied

    11.2.9. Corporate Tax Structure

    11.2.10. Investments

    11.2.11. Major Companies

    11.3. Asia-Pacific DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.4. Asia-Pacific DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.5. Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.6. Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.7. Asia-Pacific DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.8. Asia Pacific DTP Vaccines Market: Country Analysis

    11.9. China Market

    11.10. Summary

    11.11. Market Overview

    11.11.1. Country Information

    11.11.2. Market Information

    11.11.3. Background Information

    11.11.4. Government Initiatives

    11.11.5. Regulations

    11.11.6. Regulatory Bodies

    11.11.7. Major Associations

    11.11.8. Taxes Levied

    11.11.9. Corporate Tax Structure

    11.11.10. Investments

    11.11.11. Major Companies

    11.12. China DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.13. China DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.14. China DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.15. China DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.16. China DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.17. India Market

    11.18. India DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.19. India DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.20. India DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.21. India DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.22. India DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.23. Japan Market

    11.24. Japan DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.25. Japan DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.26. Japan DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.27. Japan DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.28. Japan DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.29. Australia Market

    11.30. Australia DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.31. Australia DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.32. Australia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.33. Australia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.34. Australia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.35. Indonesia Market

    11.36. Indonesia DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.37. Indonesia DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.38. Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.39. Indonesia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.40. Indonesia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.41. South Korea Market

    11.42. South Korea DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    11.43. South Korea DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    11.44. South Korea DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.45. South Korea DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    11.46. South Korea DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12. Western Europe Market

    12.1. Summary

    12.2. Market Overview

    12.2.1. Region Information

    12.2.2. Market Information

    12.2.3. Background Information

    12.2.4. Government Initiatives

    12.2.5. Regulations

    12.2.6. Regulatory Bodies

    12.2.7. Major Associations

    12.2.8. Taxes Levied

    12.2.9. Corporate Tax Structure

    12.2.10. Investments

    12.2.11. Major Companies

    12.3. Western Europe DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.4. Western Europe DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.5. Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.6. Western Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.7. Western Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.8. Western Europe DTP Vaccines Market: Country Analysis

    12.9. UK Market

    12.10. UK DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.11. UK DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.12. UK DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.13. UK DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.14. UK DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.15. Germany Market

    12.16. Germany DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.17. Germany DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.18. Germany DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.19. Germany DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.20. Germany DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.21. France Market

    12.22. France DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    12.23. France DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    12.24. France DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.25. France DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    12.26. France DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13. Eastern Europe Market

    13.1. Summary

    13.2. Market Overview

    13.2.1. Region Information

    13.2.2. Market Information

    13.2.3. Background Information

    13.2.4. Government Initiatives

    13.2.5. Regulations

    13.2.6. Regulatory Bodies

    13.2.7. Major Associations

    13.2.8. Taxes Levied

    13.2.9. Corporate Tax Structure

    13.2.10. Investments

    13.2.11. Major Companies

    13.3. Eastern Europe DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.4. Eastern Europe DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.5. Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.6. Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.7. Eastern Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.8. Eastern Europe DTP Vaccines Market: Country Analysis

    13.9. Russia Market

    13.10. Russia DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    13.11. Russia DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    13.12. Russia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.13. Russia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    13.14. Russia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14. North America Market

    14.1. Summary

    14.2. Market Overview

    14.2.1. Region Information

    14.2.2. Market Information

    14.2.3. Background Information

    14.2.4. Government Initiatives

    14.2.5. Regulations

    14.2.6. Regulatory Bodies

    14.2.7. Major Associations

    14.2.8. Taxes Levied

    14.2.9. Corporate tax structure

    14.2.10. Investments

    14.2.11. Major Companies

    14.3. North America DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.4. North America DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.5. North America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.6. North America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.7. North America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.8. North America DTP Vaccines Market: Country Analysis

    14.9. USA Market

    14.10. Summary

    14.11. Market Overview

    14.11.1. Country Information

    14.11.2. Market Information

    14.11.3. Background Information

    14.11.4. Government Initiatives

    14.11.5. Regulations

    14.11.6. Regulatory Bodies

    14.11.7. Major Associations

    14.11.8. Taxes Levied

    14.11.9. Corporate Tax Structure

    14.11.10. Investments

    14.11.11. Major Companies

    14.12. USA DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    14.13. USA DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    14.14. USA DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.15. USA DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    14.16. USA DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15. South America Market

    15.1. Summary

    15.2. Market Overview

    15.2.1. Region Information

    15.2.2. Market Information

    15.2.3. Background Information

    15.2.4. Government Initiatives

    15.2.5. Regulations

    15.2.6. Regulatory Bodies

    15.2.7. Major Associations

    15.2.8. Taxes Levied

    15.2.9. Corporate Tax Structure

    15.2.10. Investments

    15.2.11. Major Companies

    15.3. South America DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    15.4. South America DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    15.5. South America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.6. South America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.7. South America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.8. South America DTP Vaccines Market: Country Analysis

    15.9. Brazil Market

    15.10. Brazil DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    15.11. Brazil DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    15.12. Brazil DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.13. Brazil DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    15.14. Brazil DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16. Middle East Market

    16.1. Summary

    16.2. Market Overview

    16.2.1. Region Information

    16.2.2. Market Information

    16.2.3. Background Information

    16.2.4. Government Initiatives

    16.2.5. Regulations

    16.2.6. Regulatory Bodies

    16.2.7. Major Associations

    16.2.8. Taxes Levied

    16.2.9. Corporate Tax Structure

    16.2.10. Investments

    16.2.11. Major Companies

    16.3. Middle East DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    16.4. Middle East DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    16.5. Middle East DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.6. Middle East DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    16.7. Middle East DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17. Africa Market

    17.1. Summary

    17.2. Market Overview

    17.2.1. Region Information

    17.2.2. Market Information

    17.2.3. Background Information

    17.2.4. Government Initiatives

    17.2.5. Regulations

    17.2.6. Regulatory Bodies

    17.2.7. Major Associations

    17.2.8. Taxes Levied

    17.2.9. Corporate Tax Structure

    17.2.10. Investments

    17.2.11. Major Companies

    17.3. Africa DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

    17.4. Africa DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

    17.5. Africa DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.6. Africa DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    17.7. Africa DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

    18. Competitive Landscape And Company Profiles

    18.1. Company Profiles

    18.2. GlaxoSmithKline plc

    18.2.1. Company Overview

    18.2.2. Products And Services

    18.2.3. Business Strategy

    18.2.4. Financial Overview

    18.3. Sanofi SA

    18.3.1. Company Overview

    18.3.2. Products And Services

    18.3.3. Business Strategy

    18.3.4. Financial Overview

    18.4. Merck & Co. Inc.

    18.4.1. Company Overview

    18.4.2. Products And Services

    18.4.3. Business Strategy

    18.4.4. Financial Overview

    18.5. Meiji Holdings Co., Ltd

    18.5.1. Company Overview

    18.5.2. Products And Services

    18.5.3. Business Strategy

    18.5.4. Financial Overview

    18.6. Shenzhen Kangtai Biological Products

    18.6.1. Company Overview

    18.6.2. Products And Services

    18.6.3. Business Strategy

    18.6.4. Financial Overview

    19. DTP Vaccines Pipeline Analysis

    20. Key Mergers And Acquisitions

    20.1. Sanofi S.A. Acquired Kymab Ltd

    20.2. Merck & Co Acquired Pandion Therapeutics

    20.3. Novartis AG Acquired The Medicines Company

    20.4. BioNTech SE Acquired GMP Certified Manufacturing Site Of Novartis AG

    20.5. Sanofi SA Acquired Synthrox

    20.6. Bharat Biotech International Limited Acquired Chiron Behring Vaccines From GlaxoSmithKline

    20.7. Bavarian Nordic A/S Acquired Global Rights For Two Vaccines from GSK

    21. Future Outlook and Potential Analysis

    21.1. Global DTP Vaccines Market In 2026 – Countries Offering Most New Opportunities

    21.2. Global DTP Vaccines Market In 2026 – Segments Offering Most New Opportunities

    21.3. Global DTP Vaccines Market In 2026 – Growth Strategies

    21.3.1. Market Trend Based Strategies

    21.3.2. Competitor Strategies

    22. Appendix

    22.1. Market Data Sources

    22.2. Research Methodology

    22.3. Currencies

    22.4. The Business Research Company

    23. Copyright and Disclaimer

List Of Tables

    Table 1: Global DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 2: Global DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3: Global DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4: Global DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5: Global DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6: Global DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7: Global DTP Vaccines Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8: Global DTP Vaccines Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9: Global DTP Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10: Global DTP Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11: Global DTP Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12: Global DTP Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 14: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 17: Asia-Pacific DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 18: Asia-Pacific DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 19: Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 20: Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 21: Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 22: Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 23: Asia-Pacific DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 24: Asia-Pacific DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 25: China Population By Age Group, 2016-2026, Thousands
  • Table 26: China GDP Per Capita, 2016-2021, $
  • Table 27:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 28: China DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 29: China DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 30: China DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 31: China DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 32: China DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 33: China DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 34: China DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35: China DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36: India DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 37: India DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 38: India DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39: India DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40: India DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 41: India DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 42: India DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43: India DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44: Japan DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 45: Japan DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 46: Japan DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47: Japan DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48: Japan DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 49: Japan DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 50: Japan DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51: Japan DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52: Australia DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 53: Australia DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 54: Australia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 55: Australia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 56: Australia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 57: Australia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 58: Australia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 59: Australia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 60: Indonesia DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 61: Indonesia DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 62: Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 63: Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 64: Indonesia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 65: Indonesia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 66: Indonesia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 67: Indonesia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 68: South Korea DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 69: South Korea DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 70: South Korea DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 71: South Korea DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 72: South Korea DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 73: South Korea DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 74: South Korea DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 75: South Korea DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 76: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 77: Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 78:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 79:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 80: Western Europe DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 81: Western Europe DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 82: Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 83: Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 84: Western Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 85: Western Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 86: Western Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 87: Western Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 88: UK DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 89: UK DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 90: UK DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 91: UK DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 92: UK DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 93: UK DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 94: UK DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 95: UK DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 96: Germany DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 97: Germany DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 98: Germany DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 99: Germany DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 100: Germany DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 101: Germany DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 102: Germany DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 103: Germany DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 104: France DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 105: France DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 106: France DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 107: France DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 108: France DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 109: France DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 110: France DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 111: France DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 112: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 113: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 114:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 115:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 116: Eastern Europe DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 117: Eastern Europe DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 118: Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 119: Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 120: Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 121: Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 122: Eastern Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 123: Eastern Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 124: Russia DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 125: Russia DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 126: Russia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 127: Russia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 128: Russia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 129: Russia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 130: Russia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 131: Russia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 132: North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 133: North America GDP Per Capita, By Country, 2016-2021, $
  • Table 134:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 135:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 136: North America DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 137: North America DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 138: North America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 139: North America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 140: North America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 141: North America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 142: North America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 143: North America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 144: USA Population By Age Group, 2016-2026, Thousands
  • Table 145: USA GDP Per Capita, 2016-2021, $
  • Table 146:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 147: USA DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 148: USA DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 149: USA DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 150: USA DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 151: USA DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 152: USA DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 153: USA DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 154: USA DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 155: South America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 156: South America GDP Per Capita, By Country, 2016-2021, $
  • Table 157:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 158:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 159: South America DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 160: South America DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 161: South America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 162: South America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 163: South America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 164: South America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 165: South America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 166: South America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 167: Brazil DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 168: Brazil DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 169: Brazil DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 170: Brazil DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 171: Brazil DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 172: Brazil DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 173: Brazil DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 174: Brazil DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 175: Middle East Population By Age Group, By Country, 2016-2026, Thousands
  • Table 176: Middle East GDP Per Capita, By Country, 2016-2021, $
  • Table 177:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 178:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 179: Middle East DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 180: Middle East DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 181: Middle East DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 182: Middle East DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 183: Middle East DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 184: Middle East DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 185: Middle East DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 186: Middle East DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 187: Africa Population By Age Group, By Country, 2016-2026, Thousands
  • Table 188: Africa GDP Per Capita, By Country, 2016-2021, $
  • Table 189:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 190:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 191: Africa DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Table 192: Africa DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 193: Africa DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 194: Africa DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 195: Africa DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 196: Africa DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 197: Africa DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 198: Africa DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 199: Global DTP Vaccines Manufacturing Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Table 200: GlaxoSmithKline plc – Financial Performance, 2017 – 2021, $ Billion
  • Table 201: Sanofi SA – Financial Overview, 2017 - 2021, $ Billion
  • Table 202: Merck & Co. Inc. –  Financial Overview, 2017 - 2021, $ Billion
  • Table 203: Meiji Holdings Co., Ltd –  Financial Overview, 2017 - 2021, $ Billion
  • Table 204: Shenzhen Kangtai Biological Products –  Financial Overview, 2017 - 2021, $ Billion
  • Table 205: Global DTP Vaccine Market, Product Pipeline Analysis
  • Table 206: Global DTP Vaccines Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 207: Global DTP Vaccines Market Size Gain ($ Million), Segmentation By Product Type, 2021 – 2026
  • Table 208: Global DTP Vaccines Market Size Gain ($ Million), Segmentation By Disease, 2021 – 2026
  • Table 209: Global DTP Vaccines Market Size Gain ($ Million), Segmentation By End User, 2021 – 2026
  • Table 210: DTP Vaccines - Market Data Sources

List Of Figures

    Figure 1: Geographic Regions Covered
  • Figure 2: Global DTP Vaccines Market Segmentation By Product Type
  • Figure 3: Global DTP Vaccines Market Segmentation By Disease
  • Figure 4: Global DTP Vaccines Market Segmentation By End User
  • Figure 5: Global DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 6: Global DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 7: Global DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8: Global DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9: Global DTP Vaccines Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10: Global DTP Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11: Global DTP Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 12: Asia-Pacific DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 13: Asia-Pacific DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 14: Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 15: Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 16: Asia-Pacific DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 17: China DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 18: China DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 19: China DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 20: China DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 21: China DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 22: India DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 23: India DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 24: India DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 25: India DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 26: India DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 27: Japan DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 28: Japan DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 29: Japan DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 30: Japan DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 31: Japan DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F,
  • Figure 32: Australia DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 33: Australia DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 34: Australia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35: Australia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 36: Australia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 37: Indonesia DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 38: Indonesia DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 39: Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 40: Indonesia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 41: Indonesia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 42: South Korea DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 43: South Korea DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 44: South Korea DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 45: South Korea DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 46: South Korea DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 47: Western Europe DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 48: Western Europe DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 49: Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50: Western Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 51: Western Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 52: UK DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 53: UK DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 54: UK DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 55: UK DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 56: UK DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 57: Germany DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 58: Germany DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 59: Germany DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 60: Germany DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 61: Germany DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 62: France DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 63: France DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 64: France DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 65: France DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 66: France DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 67: Eastern Europe DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 68: Eastern Europe DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 69: Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 70: Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 71: Eastern Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 72: Russia DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 73: Russia DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 74: Russia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 75: Russia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 76: Russia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 77: North America DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 78: North America DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 79: North America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 80: North America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 81: North America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 82: USA DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 83: USA DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 84: USA DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 85: USA DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86: USA DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 87: South America DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 88: South America DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 89: South America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 90: South America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 91: South America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 92: Brazil DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 93: Brazil DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 94: Brazil DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 95: Brazil DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 96: Brazil DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 97: Middle East DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 98: Middle East DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 99: Middle East DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 100: Middle East DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 101: Middle East DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 102: Africa DTP Vaccines Market, Historic, 2016 – 2021, $ Million
  • Figure 103: Africa DTP Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 104: Africa DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 105: Africa DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 106: Africa DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 107: Global DTP Vaccines Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
  • Figure 108: GlaxoSmithKline plc – Financial Performance, 2017 – 2021, $ Billion
  • Figure 109: Sanofi SA – Financial Overview, 2017 – 2021, $ Billion
  • Figure 110: Merck & Co. Inc. – Financial Overview 2017 –  2021, $ Billion
  • Figure 111: Meiji Holdings Co., Ltd – Financial Overview 2017 –  2021, $ Billion
  • Figure 112: Shenzhen Kangtai Biological Products – Financial Overview 2017 –  2021, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report